Skip to main content
. 2021 Jan 1;8(1):109–123. doi: 10.3233/JND-200563

Table 2.

Disease characteristics, all individuals with SMA types I, II, and III

Characteristics 2018 Survey 2017 Survey
Type I Type II Type III Type I Type II Type III
(n = 268) (n = 290) (n = 173) (n = 213) (n = 270) (n = 187)
Age at symptom onset
N 258 272 159
  Mean (SD), months 2.6 (3.9) 10.2 (10.4) 39.4 (70.6) NC NC NC
  Median (range), months 2 (0–49) 9 (0–160) 18 (0–680) NC NC NC
Age at diagnosis
N 263 280 167 203 243 167
  Mean (SD), months 5.2 (10.7) 22.9 (33.1) 114.4 (119.8) 4.9 (9.6) 21.7 (36.9) 107.5 (126.2)
  Median (range), months*, † 4 16 59 4 16 46
(–6 to 128) (–7 to 310) (–6 to 587) (–9 to 126) (–6 to 520) (–5 to 587)
Diagnostic delay
N 226 242 138
  Mean (SD), months 5.7 (33.4) 15.9 (39.7) 89.4 (111.8) NC NC NC
  Median (range), months 2 (0–437) 7 (0–329) 37 (0–547) NC NC NC
SMN2 copy number, n (%)
  1 copy 19 (7.1) 3 (1.0) 1 (0.6) 14 (6.6) 6 (2.2) 1 (0.5)
  2 copies 117 (43.7) 27 (9.3) 10 (5.8) 85 (39.9) 16 (5.9) 5 (2.7)
  3 copies 16 (6.0) 112 (38.6) 36 (20.8) 7 (3.3) 83 (30.7) 29 (15.5)
  4 copies 0 5 (1.7) 39 (22.5) 1 (0.5) 0 19 (10.2)
  5 or more copies 1 (0.4) 0 6 (3.5) 0 1 (0.4) 3 (1.6)
  Don’t know/missing 115 (42.9) 143 (49.3) 81 (46.8) 106 (49.8) 164 (60.7) 130 (69.5)

NC, not collected; SMA, spinal muscular atrophy. *Excluded values of <-9 months. Negative values indicate diagnosis before birth. Diagnostic delay = age at diagnosis minus age at symptom onset. If diagnostic delay was negative (child started to show symptoms after receiving a diagnosis), the negative value was edited to “0” to indicate no diagnostic delay.